PTC Therapeutics, Inc. today announced a corporate update and reported financial results for the second quarter ended June 30, 2014....
Read more-- Third quarter revenue of $398 million declined 6 percent versus prior year -- Adjusted diluted earnings per share for...
Read morePar Pharmaceutical Companies, Inc. announced today that it will host a conference call on Wednesday, August 13, 2014 at 10:00...
Read moreOrexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced corporate and financial results...
Read moreNPS Pharmaceuticals, Inc., a global biopharmaceutical company pioneering and delivering innovative therapies that transform the lives of patients with rare...
Read moreCardiome Pharma Corp. today announced that it will report financial results for the second quarter ended June 30, 2014 on...
Read moreTherapath LLC (www.Therapath.com),a leader in neuropathology laboratory services, has established normative values for two upper limb body sites that can...
Read moreThe Immune Deficiency Foundation (IDF) is pleased to announce that the enrollment for the Medicare IVIG Demonstration Project will begin...
Read moreSynergy Pharmaceuticals Inc., today announced its Chairman and Chief Executive Officer, Dr. Gary S. Jacob, will present a corporate update...
Read moreNeurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter ended June 30, 2014. For the second...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
